U.S., April 30 -- ClinicalTrials.gov registry received information related to the study (NCT07556237) titled 'Gastric Electrical Stimulation for Abdominal Pain in Patients With Gastroparesis' on April 09.
Brief Summary: Gastroparesis is a disorder characterized by delayed gastric emptying and symptoms including nausea, vomiting, and abdominal pain. Gastric electrical stimulation (GES) using the implanted Enterra™ neurostimulator is FDA-approved to treat nausea and vomiting but its impact on abdominal pain has not been well studied. This study evaluates whether alternative programming parameters of the Enterra™ device can reduce abdominal pain in patients with gastroparesis. Participants with an existing Enterra™ device wi...